Table 7.

Survival outcomes per treatment group: no (CRT, BSC), single (P or M) or double (P + M) local treatments. mOS = median overall survival; P = local primary pancreatic treatment; M = local metastatic treatment; CRT = chemo(radio)therapy; BSC = best supportive care; Sc = synchronous; Mc = metachronous. * Data from Liu et al. [66], not included in the articles selected for this systematic review.

(Locoregional) Treatments	Hepatic mPDAC mOS from Metastatic Diagnosis/Treatment	Pulmonary mPDAC mOS from Metastatic Diagnosis/Treatment
P + M	7.8–19 (Sc + Mc)	22.8–47 (Sc + Mc)
P only	9.1–9.2 (Mc)	8.1–20.2 (Mc)
M only	7.5 (Sc)	10.7 (Mc)
CRT/BSC	4.3–7.6 (Sc + Mc)	11.8 * (Sc + Mc)